| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 142 | ISGCDRTVKELK | |||
| 10788 | ISGCDRTVKELK | |||
| 10015592 | TPSSSSLSQR | S | 4 | 591 |
| 10027247 | TTVTVPNDGGPIEAVSTIETVPYWTR | S | 16 | 234 |
| 10037529 | TTVTVPNDGGPIEAVSTIETVPYWTR | 234 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 142 | MS | HTP | ambiguous | human | HeLa cells | ionizing radiation/control | -2.064678588 | 3.80E-05 | 30379171 | |
| 10788 | MS | HTP | ambiguous | human | HeLa cells | 30379171 | ||||
| 10015592 | MS | HTP | unambiguous | human | HeLa cells | 31492838 | ||||
| 10027247 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | ||||
| 10037529 | MS | HTP | unambiguous | human | HepG2 cells | orafenib sensitive/resistant | -1.736965594 | 30620550 | Peptide quantification value was applied to each modification site |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 142 | ISGCDRTVKELK | MS | HTP | ambiguous | human | HeLa cells | 30379171 | ||||
| 10788 | ISGCDRTVKELK | MS | HTP | ambiguous | human | HeLa cells | 30379171 | ||||
| 10015592 | TPSSSSLSQR | S | 4 | 591 | MS | HTP | unambiguous | human | HeLa cells | 31492838 | |
| 10027247 | TTVTVPNDGGPIEAVSTIETVPYWTR | S | 16 | 234 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
| 10037529 | TTVTVPNDGGPIEAVSTIETVPYWTR | 234 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | Peptide quantification value was applied to each modification site |